MIRA PHARMACEUTICALS (MIRA) CFO Andriy Mushak listed as insider in Form 3
Rhea-AI Filing Summary
MIRA PHARMACEUTICALS, INC. filed an initial ownership report (Form 3) for Andriy Mushak, who serves as Chief Financial Officer. The filing does not list any transactions or holdings, functioning primarily as a baseline disclosure of his status as an officer subject to insider reporting rules.
Positive
- None.
Negative
- None.
Key Terms
Form 3, Chief Financial Officer, insider reporting
3 terms
Form 3 regulatory
"filed an initial ownership report (Form 3) for Andriy Mushak"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Chief Financial Officer financial
"Andriy Mushak, who serves as Chief Financial Officer"
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
insider reporting regulatory
"his status as an officer subject to insider reporting rules"
Insider reporting is the public disclosure of stock trades and holdings by a company’s executives, directors or large shareholders, filed with market regulators so investors can see when people with inside knowledge buy or sell. It matters because these actions can signal confidence or concern about a company’s future—much like a shop owner restocking or clearing shelves, insiders’ moves give clues about how those closest to the business view its prospects.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the MIRA Form 3 filing for Andriy Mushak show?
The Form 3 filing lists Andriy Mushak as Chief Financial Officer of MIRA PHARMACEUTICALS, INC. It establishes him as an insider subject to reporting rules but does not detail any current stock or option transactions in this specific disclosure.
What insider role does Andriy Mushak hold at MIRA PHARMACEUTICALS (MIRA)?
The filing identifies Andriy Mushak as an officer of MIRA PHARMACEUTICALS, specifically holding the title of Chief Financial Officer. This role subjects him to ongoing SEC reporting obligations regarding his beneficial ownership and future transactions in the company’s securities.
Are any derivative securities reported for Andriy Mushak in this MIRA Form 3?
No derivative securities are listed for Andriy Mushak in the provided Form 3 data. The derivative summary is empty, and the exercise and derivative transaction counts are zero, indicating no reported options, warrants, or similar instruments in this particular filing.
What does the transaction summary indicate in the MIRA Form 3 for Andriy Mushak?
The transaction summary shows zero for all buy, sell, exercise, gift, tax withholding, and restructuring categories, with a neutral net buy-sell direction. This indicates there were no reportable transactions associated with this initial ownership filing.